• Monthly
  • $25
  • $50
  • $100
  • $other
  • use PayPal

ONE WEEK TO DOUBLE YOUR DONATION!

A generous CounterPuncher has offered a $25,000 matching grant. So for this week only, whatever you can donate will be doubled up to $25,000! If you have the means, please donate! If you already have done so, thank you for your support. All contributions are tax-deductible.
FacebookTwitterRedditEmail

Dangerous, Expensive Drugs Aggressively Pushed? You Have These Medical Conflicts of Interest to Thank

Photo Source Damian Gadal | CC BY 2.0

The year was 2011. FDA Commissioner Margaret Hamburg proposed loosening conflict of interest rules for doctors sitting on advisory committees because non-compromised doctors were disappearing. The FDA could not find “knowledgeable experts who are free of financial conflicts of interest,” said news reports.

How bad is Pharma’s brazen financial infiltration into US medicine? The New York Times and ProPublica recently reported that Memorial Sloan Kettering Cancer Center’s own CEO, Dr. Craig B. Thompson, its chief medical officer, Dr. José Baselga, and one of its immunotherapy specialists, Dr. Jedd Wolchok, were swimming in Pharma money.

Thomas sat on the boards of Merck and Charles River Laboratories and actually founded a cancer start-up. Wolchok, says the Times and ProPublica, has links to 31 Pharma companies. Baselga, who has since resigned, received undisclosed millions from Pharma.

I have personally attended medical conferences where doctors unflinchingly show slide after slide of Pharma companies who pay them as if the payments did not affect their presentations to follow.

The responses of doctors exposed for the payola/bribes are downright embarrassing. Lee Cohen, lead author of a 2006 JAMA article promoting antidepressants during pregnancy listed 76 financial relationships with Pharma that he and the other authors had not mentioned explaining that, “We did not view those associations as relevant to this study.”

Entire hospital programs have been Pharma funded. Harvard child psychiatrist Joseph “Risperdal” Biederman approached Johnson & Johnson with a money-making scheme called the Johnson & Johnson Center for the Study of Pediatric Psychopathology at Massachusetts General Hospital to “move forward the commercial goals of J. & J.” and “support the safety and effectiveness of risperidone [Risperdal] in this age group.”

Dr. Mani Pavuluri, who received GlaxoSmithKline dollars, founded the Pediatric Mood Disorders Program and the Pediatric Brain Research and InterventioN (BRAIN) Center at the University of Illinois, conflicts of interest notwithstanding. She has since left in disgrace.

The corruption also affects our tax dollars. Despite leaving Emory University under a shameful cloud for not disclosing Pharma income and having a National Institutes of Health (NIH) grant terminated, Dr. Charles Nemeroff resurfaced at the University of Miami along with our tax dollars in what was widely regarded as undisguised cronyism.

Rather than stopping such conflicts of interest, mainstream medicine is moving toward legitimizing them. Dr. Timothy Wilens, chief of the division of child and adolescent psychiatry at Massachusetts General Hospital readily admits his “ties” to Pharma saying he has “an academic obligation to work with the industry.”

Duke’s Dr. Robert Califf, who became FDA Commissioner after Hamburg,said, “many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.”

A disclosure statement on the website of Duke Clinical Research Institute says “Robert M. Califf, MD, reports receiving research grant support from Novartis Pharmaceuticals, Johnson & Johnson/Scios, Lilly, Merck, and Schering Plough, and consulting fees from Annenberg, Aterovax, Bayer/Ortho McNeil, BMS, Boehringer Ingelheim, GSK, WebMd/theheart.org, Johnson and Johnson/Scios, Kowa Research Institute, McKinsey & Company, Medtronic, Merck, Novartis Pharmaceuticals, Sanofi Aventis, and Schering Plough, and has an equity position with NITROX, LLC.”

Since Califf, Pharma operative Scott Gottlieb now heads the FDA and former Eli Lilly lobbyist Alex Azar now heads Health and Human Services in a clear message that government officials with Pharma ties are fine.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
October 21, 2019
Jeffrey St. Clair
The Wolf at the Door: Adventures in Fundraising With Cockburn
Rev. William Alberts
Myopic Morality: The Rehabilitation of George W. Bush
Sheldon Richman
Let’s Make Sure the Nazis Killed in Vain
Horace G. Campbell
Chinese Revolution at 70: Twists and Turns, to What?
Jim Kavanagh
The Empire Steps Back
Ralph Nader
Where are the Influentials Who Find Trump Despicable?
Thomas Knapp
Excuses, Excuses: Now Hillary Clinton’s Attacking Her Own Party’s Candidates
stclair
Taking Next Steps Toward Nuclear Abolition
Brian Terrell
The United States Air Force at Incirlik, Our National “Black Eye”
Paul Bentley
A Plea for More Cynicism, Not Less: Election Day in Canada
Walter Clemens
No Limits to Evil?
Robert Koehler
The Collusion of Church and State
Kathy Kelly
Taking Next Steps Toward Nuclear Abolition
Charlie Simmons
How the Tax System Rewards Polluters
Chuck Collins
Who is Buying Seattle? The Perils of the Luxury Real Estate Boom
Weekend Edition
October 18, 2019
Friday - Sunday
Anthony DiMaggio
Trump as the “Anti-War” President: on Misinformation in American Political Discourse
Jeffrey St. Clair
Roaming Charges: Where’s the Beef With Billionaires?
Rob Urie
Capitalism and the Violence of Environmental Decline
Paul Street
Bernie in the Deep Shit: Dismal Dem Debate Reflections
Andrew Levine
What’s So Awful About Foreign Interference?
T.J. Coles
Boris Johnson’s Brexit “Betrayal”: Elect a Clown, Expect a Pie in Your Face
Joseph Natoli
Trump on the March
Ashley Smith
Stop the Normalization of Concentration Camps
Pete Dolack
The Fight to Overturn the Latest Corporate Coup at Pacifica Has Only Begun
Jeremy Kuzmarov
Russophobia at Democratic Party Debate
Chris Gilbert
Forward! A Week of Protest in Catalonia
Daniel Beaumont
Pressing Done Here: Syria, Iraq and “Informed Discussion”
Daniel Warner
Greta the Disturber
John Kendall Hawkins
Journey to the Unknown Interior of (You)
M. G. Piety
“Grim Positivism” vs. Truthiness in Biography
Christopher Fons – Conor McMullen
The Centrism of Elizabeth Warren
Nino Pagliccia
Peace Restored in Ecuador, But is trust?
Rebecca Gordon
Extorting Ukraine is Bad Enough But Trump Has Done Much Worse
Kathleen Wallace
Trump Can’t Survive Where the Bats and Moonlight Laugh
Clark T. Scott
Cross-eyed, Fanged and Horned
Eileen Appelbaum
The PR Campaign to Hide the Real Cause of those Sky-High Surprise Medical Bills
Olivia Alperstein
Nuclear Weapons are an Existential Threat
Colin Todhunter
Asia-Pacific Trade Deal: Trading Away Indian Agriculture?
Sarah Anderson
Where is “Line Worker Barbie”?
Brian Cloughley
Yearning to Breathe Free
Jill Richardson
Why are LGBTQ Rights Even a Debate?
Jesse Jackson
What I Learn While Having Lunch at Cook County Jail
Kathy Kelly
Death, Misery and Bloodshed in Yemen
Maximilian Werner
Leadership Lacking for Wolf Protection
Arshad Khan
The Turkish Gambit
FacebookTwitterRedditEmail